Key result
Living donor liver transplantation was performed safely in a patient continuing dual antiplatelet therapy, with no evidence of excessive bleeding or cardiac ischemia.
Why the study?
Does continuation of dual antiplatelet therapy (clopidogrel and aspirin) prevent cardiac ischemia without excessive bleeding in a patient with recent drug-eluting stents undergoing living donor liver transplantation?
Case Report (n=1)
No
Does continuation of dual antiplatelet therapy (clopidogrel and aspirin) prevent cardiac ischemia without excessive bleeding in a patient with recent drug-eluting stents undergoing living donor liver transplantation?
Living donor liver transplantation can be performed safely in a patient on dual antiplatelet therapy when guided by careful preoperative evaluation of coagulation using thromboelastography and platelet mapping.
Answers are grounded in this paper and cite their sources.
May support perioperative dual antiplatelet continuation in select cases; leaves open need for prospective validation before practice change.
We report a case of a patient who underwent Living Donor Liver Transplantation (LDLT) while being continued on his dual antiplatelet regimen of clopidigrel and aspirin perioperatively. The patient had two drug eluting stents for coronary artery disease placed eight months prior to surgery. Preoperative thromboelastography and platelet mapping showed normal clot formation. Based on these tests it was determined that preoperative platelet transfusion was not necessary. The surgery proceeded relatively uneventfully. The patient received 1 unit of packed red blood cells intraoperatively and continued on aspirin during the postoperative period with no evidence of bleeding or cardiac ischemia.
No takes yet. Share an insight, caveat, or question.
Moguilevitch et al. (2013) conducted a case report in End stage liver disease and coronary artery disease with drug eluting stents (n=1). Continuation of dual antiplatelet therapy (clopidogrel and aspirin) was evaluated on Perioperative bleeding or cardiac ischemia. Living donor liver transplantation was performed safely in a patient continuing dual antiplatelet therapy, with no evidence of excessive bleeding or cardiac ischemia.
Synapse has enriched 10 related papers. Consider them for comparative context: